|
STOCK INCENTIVE PLANS AND SHARE-BASED COMPENSATION (Tables)
|
12 Months Ended |
|
Mar. 31, 2015
|
| Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
|
| Schedule of assumptions used in calculating fair values |
The weighted-average fair values and the assumptions used in calculating fair values during each fiscal period are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended March 31, |
|
2015 |
|
2014 |
|
2013 |
Option life (in years) |
0.5 |
|
|
0.5 |
|
|
0.5 |
|
Risk-free interest rate |
0.07 |
% |
|
0.07 |
% |
|
0.13 |
% |
Stock price volatility |
36.58 |
% |
|
43.71 |
% |
|
69.73 |
% |
Weighted-average grant date fair value |
$ |
0.36 |
|
|
$ |
0.40 |
|
|
$ |
0.48 |
|
|
| Summary of share-based compensation expense |
The following tables summarize share-based compensation expense (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended March 31, |
|
2015 |
|
2014 |
|
2013 |
Share-based compensation expense: |
|
|
|
|
|
Cost of revenue |
$ |
1,489 |
|
|
$ |
1,963 |
|
|
$ |
2,389 |
|
Research and development |
2,559 |
|
|
3,430 |
|
|
3,665 |
|
Sales and marketing |
3,506 |
|
|
4,097 |
|
|
4,699 |
|
General and administrative |
4,029 |
|
|
3,969 |
|
|
4,386 |
|
Total share-based compensation expense |
$ |
11,583 |
|
|
$ |
13,459 |
|
|
$ |
15,139 |
|
|
| Schedule of share-based compensation by type of award |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended March 31, |
|
2015 |
|
2014 |
|
2013 |
Share-based compensation by type of award: |
|
|
|
|
|
Stock options |
$ |
617 |
|
|
$ |
826 |
|
|
$ |
1,681 |
|
Restricted stock |
10,102 |
|
|
11,356 |
|
|
11,630 |
|
Stock purchase plan |
864 |
|
|
1,277 |
|
|
1,828 |
|
Total share-based compensation expense |
$ |
11,583 |
|
|
$ |
13,459 |
|
|
$ |
15,139 |
|
|
| Schedule of activity relating to stock option plans |
A summary of activity relating to all of our stock option plans is as follows (stock options and intrinsic value in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Options |
|
Weighted-
Average
Exercise Price
|
|
Weighted-
Average
Remaining
Contractual Term
|
|
Aggregate
Intrinsic Value
|
Outstanding as of March 31, 2014 |
7,997 |
|
|
$ |
1.78 |
|
|
|
|
|
Exercised |
(866 |
) |
|
0.97 |
|
|
|
|
|
Forfeited |
(117 |
) |
|
2.14 |
|
|
|
|
|
Expired |
(2,070 |
) |
|
2.83 |
|
|
|
|
|
Outstanding as of March 31, 2015 |
4,944 |
|
|
$ |
1.47 |
|
|
1.72 |
|
$ |
2,039 |
|
Vested and expected to vest at March 31, 2015 |
4,944 |
|
|
$ |
1.47 |
|
|
1.72 |
|
$ |
2,039 |
|
Exercisable as of March 31, 2015 |
4,916 |
|
|
$ |
1.46 |
|
|
1.71 |
|
$ |
2,039 |
|
|
| Summary of information about stock options outstanding and exercisable |
The following table summarizes information about stock options outstanding and exercisable as of March 31, 2015 (stock options in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Range of Exercise Prices |
|
Stock Options
Outstanding
|
|
Weighted-
Average
Exercise
Price
|
|
Weighted-
Average
Remaining
Contractual Life
(Years)
|
|
Stock Options
Exercisable
|
|
Weighted-
Average
Exercise
Price
|
$0.11 |
|
— |
|
$0.63 |
|
52 |
|
|
$ |
0.49 |
|
|
3.20 |
|
52 |
|
|
$ |
0.49 |
|
$0.77 |
|
— |
|
$0.98 |
|
3,019 |
|
|
0.98 |
|
|
1.25 |
|
3,019 |
|
|
0.98 |
|
$1.00 |
|
— |
|
$1.35 |
|
233 |
|
|
1.15 |
|
|
1.26 |
|
233 |
|
|
1.15 |
|
$1.61 |
|
— |
|
$2.17 |
|
204 |
|
|
1.80 |
|
|
0.43 |
|
204 |
|
|
1.80 |
|
$2.52 |
|
— |
|
$2.93 |
|
1,436 |
|
|
2.53 |
|
|
2.90 |
|
1,408 |
|
|
2.53 |
|
|
|
|
|
|
|
4,944 |
|
|
$ |
1.47 |
|
|
1.72 |
|
4,916 |
|
|
$ |
1.46 |
|
|
| Summary of activity relating to restricted stock |
A summary of activity relating to our restricted stock follows (shares in thousands):
|
|
|
|
|
|
|
|
|
Shares |
|
Weighted-Average
Grant Date
Fair Value
|
Nonvested as March 31, 2014 |
12,108 |
|
|
$ |
1.80 |
|
Granted |
10,348 |
|
|
1.24 |
|
Vested |
(6,013 |
) |
|
2.10 |
|
Forfeited |
(2,652 |
) |
|
1.35 |
|
Nonvested as March 31, 2015 |
13,791 |
|
|
$ |
1.34 |
|
|